1/20
10:26 am
rxrx
Recursion Pharmaceuticals, Inc. (RXRX): A Bull Case Theory [Yahoo! Finance]
Low
Report
Recursion Pharmaceuticals, Inc. (RXRX): A Bull Case Theory [Yahoo! Finance]
1/18
12:41 pm
rxrx
JPMorgan Upgrades Recursion Pharmaceuticals, Inc. (RXRX) on FAP Treatment Prospects [Yahoo! Finance]
Medium
Report
JPMorgan Upgrades Recursion Pharmaceuticals, Inc. (RXRX) on FAP Treatment Prospects [Yahoo! Finance]
1/16
10:38 pm
rxrx
Is Recursion Pharmaceuticals (RXRX) Pricing In Its AI Drug Discovery Ambitions? [Yahoo! Finance]
Medium
Report
Is Recursion Pharmaceuticals (RXRX) Pricing In Its AI Drug Discovery Ambitions? [Yahoo! Finance]
1/15
08:09 pm
rxrx
Recursion Pharmaceuticals (RXRX) Stock Drops Despite Market Gains: Important Facts to Note [Yahoo! Finance]
Low
Report
Recursion Pharmaceuticals (RXRX) Stock Drops Despite Market Gains: Important Facts to Note [Yahoo! Finance]
1/9
06:11 am
rxrx
Recursion Pharmaceuticals (RXRX) Stock Sinks As Market Gains: What You Should Know [Yahoo! Finance]
Low
Report
Recursion Pharmaceuticals (RXRX) Stock Sinks As Market Gains: What You Should Know [Yahoo! Finance]
1/7
08:31 pm
rxrx
Recursion Pharmaceuticals (RXRX) Climbs 6.8% Ahead of Next Week's Business Updates [Yahoo! Finance]
Low
Report
Recursion Pharmaceuticals (RXRX) Climbs 6.8% Ahead of Next Week's Business Updates [Yahoo! Finance]
1/7
03:41 pm
rxrx
Lux Capital lands $1.5 billion for its largest fund ever [Yahoo! Finance]
Low
Report
Lux Capital lands $1.5 billion for its largest fund ever [Yahoo! Finance]
1/7
03:18 pm
rxrx
Lux Capital lands $1.5 billion for its largest fund ever [TechCrunch]
Low
Report
Lux Capital lands $1.5 billion for its largest fund ever [TechCrunch]
11/5/2025
06:30 am
RXRX
recursion pharmaceuticals, inc. - class a
BEAT
Report
1.6%
recursion pharmaceuticals, inc. - class a
8/5/2025
06:30 am
RXRX
recursion pharmaceuticals, inc. - class a
MISS
Report
-6.9%
recursion pharmaceuticals, inc. - class a
5/5/2025
06:00 am
RXRX
recursion pharmaceuticals, inc. - class a
MISS
Report
-15.5%
recursion pharmaceuticals, inc. - class a
2/28/2025
06:30 am
RXRX
recursion pharmaceuticals, inc. - class a
MISS
Report
-5.4%
recursion pharmaceuticals, inc. - class a
1/22
07:35 pm
rxrx
Form 4 RECURSION PHARMACEUTICAL For: Jan 20 Filed by: Gibson Christopher
Low
Report
Form 4 RECURSION PHARMACEUTICAL For: Jan 20 Filed by: Gibson Christopher
1/20
11:26 am
rxrx
Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher
Low
Report
Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher
1/12
08:21 am
rxrx
Form 8-K RECURSION PHARMACEUTICAL For: Jan 12
Low
Report
Form 8-K RECURSION PHARMACEUTICAL For: Jan 12
1/9
07:19 pm
rxrx
Form 3 RECURSION PHARMACEUTICAL For: Jan 01 Filed by: Hallett David
Low
Report
Form 3 RECURSION PHARMACEUTICAL For: Jan 01 Filed by: Hallett David
1/8
05:02 pm
rxrx
Form 4 RECURSION PHARMACEUTICAL For: Jan 06 Filed by: Borgeson Blake
Low
Report
Form 4 RECURSION PHARMACEUTICAL For: Jan 06 Filed by: Borgeson Blake
1/7
05:04 pm
rxrx
Form 4 RECURSION PHARMACEUTICAL For: Jan 05 Filed by: Gibson Christopher
Low
Report
Form 4 RECURSION PHARMACEUTICAL For: Jan 05 Filed by: Gibson Christopher
1/6
05:48 pm
rxrx
Form 4 RECURSION PHARMACEUTICAL For: Jan 02 Filed by: Li Dean Y
Medium
Report
Form 4 RECURSION PHARMACEUTICAL For: Jan 02 Filed by: Li Dean Y
1/6
05:48 pm
rxrx
Form 4 RECURSION PHARMACEUTICAL For: Jan 02 Filed by: Dar Zavain
Medium
Report
Form 4 RECURSION PHARMACEUTICAL For: Jan 02 Filed by: Dar Zavain
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register